Structure

Physi-Chem Properties

Molecular Weight:  422.21
Volume:  458.726
LogP:  4.521
LogD:  3.534
LogS:  -4.306
# Rotatable Bonds:  10
TPSA:  86.99
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.278
Synthetic Accessibility Score:  3.266
Fsp3:  0.269
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.878
MDCK Permeability:  1.9383478502277285e-05
Pgp-inhibitor:  0.379
Pgp-substrate:  0.372
Human Intestinal Absorption (HIA):  0.024
20% Bioavailability (F20%):  0.012
30% Bioavailability (F30%):  0.005

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.024
Plasma Protein Binding (PPB):  100.23887634277344%
Volume Distribution (VD):  0.305
Pgp-substrate:  0.4915429353713989%

ADMET: Metabolism

CYP1A2-inhibitor:  0.792
CYP1A2-substrate:  0.933
CYP2C19-inhibitor:  0.777
CYP2C19-substrate:  0.138
CYP2C9-inhibitor:  0.844
CYP2C9-substrate:  0.946
CYP2D6-inhibitor:  0.806
CYP2D6-substrate:  0.9
CYP3A4-inhibitor:  0.525
CYP3A4-substrate:  0.273

ADMET: Excretion

Clearance (CL):  8.575
Half-life (T1/2):  0.735

ADMET: Toxicity

hERG Blockers:  0.121
Human Hepatotoxicity (H-HT):  0.362
Drug-inuced Liver Injury (DILI):  0.071
AMES Toxicity:  0.259
Rat Oral Acute Toxicity:  0.137
Maximum Recommended Daily Dose:  0.944
Skin Sensitization:  0.937
Carcinogencity:  0.386
Eye Corrosion:  0.003
Eye Irritation:  0.15
Respiratory Toxicity:  0.761

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470211

Natural Product ID:  NPC470211
Common Name*:   Xanthoangelol G
IUPAC Name:   (E)-1-[2-hydroxy-3-[(2E)-6-hydroxy-3,7-dimethylocta-2,7-dienyl]-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
Synonyms:   Xanthoangelol G
Standard InCHIKey:  NYGYGFOLOACYGB-NKUGMWFWSA-N
Standard InCHI:  InChI=1S/C26H30O5/c1-17(2)23(28)14-6-18(3)5-12-22-25(31-4)16-13-21(26(22)30)24(29)15-9-19-7-10-20(27)11-8-19/h5,7-11,13,15-16,23,27-28,30H,1,6,12,14H2,2-4H3/b15-9+,18-5+
SMILES:  CC(=C)C(CCC(=CCC1=C(C=CC(=C1O)C(=O)C=CC2=CC=C(C=C2)O)OC)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1823414
PubChem CID:   42607536
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0001630] Chalcones and dihydrochalcones
          • [CHEMONTID:0003509] 3-prenylated chalcones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21056 Angelica keiskei Species Apiaceae Eukaryota exudates n.a. n.a. PMID[16441065]
NPO21056 Angelica keiskei Species Apiaceae Eukaryota stems n.a. n.a. PMID[18558745]
NPO21056 Angelica keiskei Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[21824777]
NPO21056 Angelica keiskei Species Apiaceae Eukaryota stems n.a. n.a. PMID[25891102]
NPO21056 Angelica keiskei Species Apiaceae Eukaryota n.a. n.a. Database[FooDB]
NPO21056 Angelica keiskei Species Apiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21056 Angelica keiskei Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21056 Angelica keiskei Species Apiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2228 Individual Protein Neuraminidase Influenza A virus (strain A/Brevig Mission/1/1918 H1N1) (Influenza Avirus (strain A/South Carolina/1/1918 H1N1)) IC50 = 24200.0 nM PMID[552654]
NPT2228 Individual Protein Neuraminidase Influenza A virus (strain A/Brevig Mission/1/1918 H1N1) (Influenza Avirus (strain A/South Carolina/1/1918 H1N1)) Ki = 20000.0 nM PMID[552654]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470211 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9852 High Similarity NPC470087
0.9852 High Similarity NPC321980
0.9774 High Similarity NPC98115
0.9774 High Similarity NPC150399
0.9774 High Similarity NPC249606
0.9774 High Similarity NPC186838
0.9774 High Similarity NPC12165
0.9774 High Similarity NPC1486
0.9774 High Similarity NPC477243
0.9774 High Similarity NPC477244
0.9774 High Similarity NPC477242
0.9774 High Similarity NPC41461
0.9774 High Similarity NPC274109
0.9774 High Similarity NPC25287
0.9774 High Similarity NPC66349
0.9774 High Similarity NPC168105
0.9708 High Similarity NPC301751
0.9708 High Similarity NPC476178
0.9708 High Similarity NPC117836
0.9708 High Similarity NPC51887
0.9708 High Similarity NPC475705
0.9708 High Similarity NPC245482
0.9706 High Similarity NPC470089
0.9701 High Similarity NPC472419
0.9701 High Similarity NPC153979
0.9701 High Similarity NPC317119
0.9699 High Similarity NPC131039
0.9699 High Similarity NPC13575
0.9699 High Similarity NPC156092
0.9635 High Similarity NPC148545
0.9632 High Similarity NPC219917
0.9632 High Similarity NPC48624
0.9632 High Similarity NPC326109
0.9632 High Similarity NPC259166
0.9632 High Similarity NPC144118
0.9632 High Similarity NPC215311
0.9632 High Similarity NPC213659
0.9632 High Similarity NPC204985
0.9632 High Similarity NPC172250
0.9632 High Similarity NPC80962
0.963 High Similarity NPC21350
0.963 High Similarity NPC471620
0.9624 High Similarity NPC103842
0.9624 High Similarity NPC164136
0.9624 High Similarity NPC286336
0.9568 High Similarity NPC316769
0.9565 High Similarity NPC143896
0.9565 High Similarity NPC91560
0.9565 High Similarity NPC221432
0.9565 High Similarity NPC310130
0.9565 High Similarity NPC164980
0.9565 High Similarity NPC75049
0.9565 High Similarity NPC149026
0.9565 High Similarity NPC169591
0.9565 High Similarity NPC68104
0.9565 High Similarity NPC39329
0.9565 High Similarity NPC175504
0.9565 High Similarity NPC257097
0.9565 High Similarity NPC150408
0.9562 High Similarity NPC55832
0.9562 High Similarity NPC469404
0.9562 High Similarity NPC268204
0.9562 High Similarity NPC52789
0.9562 High Similarity NPC26051
0.9559 High Similarity NPC472366
0.9559 High Similarity NPC295384
0.9559 High Similarity NPC283429
0.9559 High Similarity NPC477956
0.9549 High Similarity NPC294593
0.9549 High Similarity NPC82225
0.9549 High Similarity NPC159623
0.9549 High Similarity NPC337373
0.9549 High Similarity NPC188646
0.9549 High Similarity NPC27643
0.9549 High Similarity NPC204960
0.9549 High Similarity NPC312318
0.9549 High Similarity NPC18877
0.9549 High Similarity NPC20560
0.9549 High Similarity NPC472365
0.9549 High Similarity NPC263670
0.9549 High Similarity NPC175098
0.9549 High Similarity NPC56031
0.9549 High Similarity NPC139813
0.9549 High Similarity NPC242294
0.9549 High Similarity NPC144051
0.9549 High Similarity NPC192304
0.9549 High Similarity NPC28753
0.95 High Similarity NPC51070
0.95 High Similarity NPC222298
0.9496 High Similarity NPC236766
0.9496 High Similarity NPC473015
0.9496 High Similarity NPC209040
0.9496 High Similarity NPC473013
0.9496 High Similarity NPC197252
0.9493 High Similarity NPC227579
0.9493 High Similarity NPC78
0.9493 High Similarity NPC194432
0.9493 High Similarity NPC324436
0.9493 High Similarity NPC328164
0.9493 High Similarity NPC265040
0.9493 High Similarity NPC177354
0.9493 High Similarity NPC10937
0.9493 High Similarity NPC228504
0.9493 High Similarity NPC296917
0.9493 High Similarity NPC66515
0.9493 High Similarity NPC166482
0.9493 High Similarity NPC148757
0.9493 High Similarity NPC64915
0.9493 High Similarity NPC40833
0.9493 High Similarity NPC1089
0.9493 High Similarity NPC125855
0.9493 High Similarity NPC182852
0.9493 High Similarity NPC324134
0.9493 High Similarity NPC107572
0.9493 High Similarity NPC223500
0.9493 High Similarity NPC306829
0.9493 High Similarity NPC76372
0.9493 High Similarity NPC161506
0.9493 High Similarity NPC32739
0.9493 High Similarity NPC37496
0.9493 High Similarity NPC166934
0.9493 High Similarity NPC167624
0.9493 High Similarity NPC76338
0.9493 High Similarity NPC220998
0.9489 High Similarity NPC101366
0.9489 High Similarity NPC11056
0.9489 High Similarity NPC253822
0.9485 High Similarity NPC243528
0.9485 High Similarity NPC251681
0.9485 High Similarity NPC124269
0.9474 High Similarity NPC129132
0.9474 High Similarity NPC257756
0.9474 High Similarity NPC87231
0.9474 High Similarity NPC212631
0.9474 High Similarity NPC205468
0.9429 High Similarity NPC472629
0.9424 High Similarity NPC214166
0.9424 High Similarity NPC77794
0.9424 High Similarity NPC223812
0.9424 High Similarity NPC478086
0.9424 High Similarity NPC185276
0.9424 High Similarity NPC316816
0.9424 High Similarity NPC107177
0.9424 High Similarity NPC125894
0.9424 High Similarity NPC81697
0.9424 High Similarity NPC85162
0.9424 High Similarity NPC278249
0.942 High Similarity NPC213322
0.942 High Similarity NPC166689
0.942 High Similarity NPC4743
0.942 High Similarity NPC96408
0.942 High Similarity NPC156190
0.942 High Similarity NPC110969
0.942 High Similarity NPC312391
0.942 High Similarity NPC17170
0.942 High Similarity NPC258630
0.942 High Similarity NPC110038
0.942 High Similarity NPC279650
0.942 High Similarity NPC248372
0.942 High Similarity NPC3188
0.942 High Similarity NPC324386
0.9416 High Similarity NPC139554
0.9412 High Similarity NPC162680
0.9412 High Similarity NPC181124
0.9412 High Similarity NPC209560
0.9412 High Similarity NPC294409
0.9412 High Similarity NPC7013
0.9412 High Similarity NPC303644
0.9412 High Similarity NPC188879
0.9412 High Similarity NPC116632
0.9407 High Similarity NPC84699
0.9398 High Similarity NPC66384
0.9398 High Similarity NPC164236
0.9398 High Similarity NPC64359
0.9398 High Similarity NPC475008
0.9398 High Similarity NPC186097
0.9398 High Similarity NPC475009
0.9398 High Similarity NPC128348
0.9398 High Similarity NPC189106
0.9398 High Similarity NPC309717
0.9398 High Similarity NPC112192
0.9398 High Similarity NPC262359
0.9398 High Similarity NPC313618
0.9398 High Similarity NPC308037
0.9366 High Similarity NPC89442
0.9362 High Similarity NPC472627
0.9362 High Similarity NPC110303
0.9362 High Similarity NPC23728
0.9357 High Similarity NPC224714
0.9357 High Similarity NPC473014
0.9357 High Similarity NPC87486
0.9357 High Similarity NPC131579
0.9357 High Similarity NPC235217
0.9357 High Similarity NPC124780
0.9357 High Similarity NPC131568
0.9357 High Similarity NPC476055
0.9357 High Similarity NPC319752
0.9357 High Similarity NPC470890
0.9353 High Similarity NPC11561
0.9353 High Similarity NPC147145

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470211 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9398 High Similarity NPD1240 Approved
0.9265 High Similarity NPD1510 Phase 2
0.9259 High Similarity NPD1607 Approved
0.9203 High Similarity NPD1549 Phase 2
0.9167 High Similarity NPD4380 Phase 2
0.913 High Similarity NPD1550 Clinical (unspecified phase)
0.913 High Similarity NPD1552 Clinical (unspecified phase)
0.9085 High Similarity NPD4378 Clinical (unspecified phase)
0.8951 High Similarity NPD7410 Clinical (unspecified phase)
0.8921 High Similarity NPD2796 Approved
0.8851 High Similarity NPD2393 Clinical (unspecified phase)
0.8844 High Similarity NPD7411 Suspended
0.88 High Similarity NPD7075 Discontinued
0.8792 High Similarity NPD8443 Clinical (unspecified phase)
0.8784 High Similarity NPD6801 Discontinued
0.8725 High Similarity NPD7096 Clinical (unspecified phase)
0.8621 High Similarity NPD6799 Approved
0.86 High Similarity NPD7819 Suspended
0.8571 High Similarity NPD6651 Approved
0.8553 High Similarity NPD4381 Clinical (unspecified phase)
0.8533 High Similarity NPD1934 Approved
0.8521 High Similarity NPD2935 Discontinued
0.8472 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8414 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.84 Intermediate Similarity NPD6599 Discontinued
0.8366 Intermediate Similarity NPD3882 Suspended
0.8366 Intermediate Similarity NPD7768 Phase 2
0.8344 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8286 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8276 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8269 Intermediate Similarity NPD6959 Discontinued
0.8264 Intermediate Similarity NPD1551 Phase 2
0.8243 Intermediate Similarity NPD1511 Approved
0.8235 Intermediate Similarity NPD2801 Approved
0.8228 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD6166 Phase 2
0.8219 Intermediate Similarity NPD2800 Approved
0.82 Intermediate Similarity NPD5403 Approved
0.8188 Intermediate Similarity NPD2533 Approved
0.8188 Intermediate Similarity NPD2532 Approved
0.8188 Intermediate Similarity NPD2534 Approved
0.8163 Intermediate Similarity NPD3750 Approved
0.8133 Intermediate Similarity NPD1512 Approved
0.8125 Intermediate Similarity NPD3818 Discontinued
0.8101 Intermediate Similarity NPD6232 Discontinued
0.8095 Intermediate Similarity NPD1243 Approved
0.8089 Intermediate Similarity NPD5494 Approved
0.8086 Intermediate Similarity NPD5953 Discontinued
0.8079 Intermediate Similarity NPD920 Approved
0.8075 Intermediate Similarity NPD7286 Phase 2
0.8069 Intermediate Similarity NPD2799 Discontinued
0.8069 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8067 Intermediate Similarity NPD5401 Approved
0.8063 Intermediate Similarity NPD7473 Discontinued
0.8054 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8042 Intermediate Similarity NPD943 Approved
0.8041 Intermediate Similarity NPD4628 Phase 3
0.8037 Intermediate Similarity NPD6559 Discontinued
0.8025 Intermediate Similarity NPD7074 Phase 3
0.7988 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7963 Intermediate Similarity NPD7054 Approved
0.7962 Intermediate Similarity NPD3749 Approved
0.7959 Intermediate Similarity NPD2344 Approved
0.7949 Intermediate Similarity NPD3817 Phase 2
0.7947 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD1203 Approved
0.7914 Intermediate Similarity NPD7472 Approved
0.7899 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7887 Intermediate Similarity NPD6832 Phase 2
0.7872 Intermediate Similarity NPD2798 Approved
0.7866 Intermediate Similarity NPD6797 Phase 2
0.7853 Intermediate Similarity NPD5844 Phase 1
0.7852 Intermediate Similarity NPD2654 Approved
0.7842 Intermediate Similarity NPD3972 Approved
0.7834 Intermediate Similarity NPD5402 Approved
0.7823 Intermediate Similarity NPD3748 Approved
0.7823 Intermediate Similarity NPD7033 Discontinued
0.7818 Intermediate Similarity NPD7251 Discontinued
0.7778 Intermediate Similarity NPD2313 Discontinued
0.7778 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7808 Phase 3
0.7763 Intermediate Similarity NPD7390 Discontinued
0.7748 Intermediate Similarity NPD2309 Approved
0.7737 Intermediate Similarity NPD9545 Approved
0.7721 Intermediate Similarity NPD9493 Approved
0.7714 Intermediate Similarity NPD9717 Approved
0.7688 Intermediate Similarity NPD919 Approved
0.7665 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7639 Intermediate Similarity NPD4908 Phase 1
0.763 Intermediate Similarity NPD4363 Phase 3
0.763 Intermediate Similarity NPD4360 Phase 2
0.7628 Intermediate Similarity NPD3226 Approved
0.7628 Intermediate Similarity NPD7458 Discontinued
0.7619 Intermediate Similarity NPD5124 Phase 1
0.7619 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD1548 Phase 1
0.7593 Intermediate Similarity NPD1247 Approved
0.759 Intermediate Similarity NPD1729 Discontinued
0.7586 Intermediate Similarity NPD3027 Phase 3
0.7552 Intermediate Similarity NPD1164 Approved
0.7546 Intermediate Similarity NPD5710 Approved
0.7546 Intermediate Similarity NPD5711 Approved
0.7545 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD3268 Approved
0.7533 Intermediate Similarity NPD6100 Approved
0.7533 Intermediate Similarity NPD6099 Approved
0.7532 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7518 Intermediate Similarity NPD422 Phase 1
0.7518 Intermediate Similarity NPD1610 Phase 2
0.7514 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3926 Phase 2
0.75 Intermediate Similarity NPD230 Phase 1
0.7486 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD4361 Phase 2
0.7483 Intermediate Similarity NPD2346 Discontinued
0.7451 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD7003 Approved
0.7431 Intermediate Similarity NPD2797 Approved
0.7431 Intermediate Similarity NPD1470 Approved
0.7429 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD5406 Approved
0.7417 Intermediate Similarity NPD5405 Approved
0.7417 Intermediate Similarity NPD5408 Approved
0.7417 Intermediate Similarity NPD5404 Approved
0.7405 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD1201 Approved
0.7383 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD4662 Approved
0.7372 Intermediate Similarity NPD1241 Discontinued
0.7372 Intermediate Similarity NPD4661 Approved
0.7361 Intermediate Similarity NPD1876 Approved
0.7351 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD4308 Phase 3
0.7315 Intermediate Similarity NPD1613 Approved
0.7315 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD6798 Discontinued
0.7297 Intermediate Similarity NPD3764 Approved
0.7294 Intermediate Similarity NPD6104 Discontinued
0.7268 Intermediate Similarity NPD7584 Approved
0.7267 Intermediate Similarity NPD37 Approved
0.7267 Intermediate Similarity NPD1933 Approved
0.7262 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD1019 Discontinued
0.7255 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD3225 Approved
0.723 Intermediate Similarity NPD4625 Phase 3
0.7222 Intermediate Similarity NPD6777 Approved
0.7222 Intermediate Similarity NPD6779 Approved
0.7222 Intermediate Similarity NPD6781 Approved
0.7222 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6778 Approved
0.7222 Intermediate Similarity NPD6776 Approved
0.7222 Intermediate Similarity NPD1608 Approved
0.7222 Intermediate Similarity NPD1465 Phase 2
0.7222 Intermediate Similarity NPD6780 Approved
0.7222 Intermediate Similarity NPD6782 Approved
0.7211 Intermediate Similarity NPD9494 Approved
0.7209 Intermediate Similarity NPD8313 Approved
0.7209 Intermediate Similarity NPD8312 Approved
0.7208 Intermediate Similarity NPD2424 Discontinued
0.7205 Intermediate Similarity NPD5890 Approved
0.7205 Intermediate Similarity NPD5889 Approved
0.72 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7192 Intermediate Similarity NPD3266 Approved
0.7192 Intermediate Similarity NPD3267 Approved
0.7183 Intermediate Similarity NPD1651 Approved
0.7181 Intermediate Similarity NPD1296 Phase 2
0.7181 Intermediate Similarity NPD411 Approved
0.7179 Intermediate Similarity NPD3887 Approved
0.7178 Intermediate Similarity NPD4288 Approved
0.7178 Intermediate Similarity NPD2296 Approved
0.7172 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD6844 Discontinued
0.716 Intermediate Similarity NPD3751 Discontinued
0.7152 Intermediate Similarity NPD447 Suspended
0.7152 Intermediate Similarity NPD6355 Discontinued
0.7143 Intermediate Similarity NPD6002 Phase 3
0.7143 Intermediate Similarity NPD6005 Phase 3
0.7143 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1471 Phase 3
0.7143 Intermediate Similarity NPD6004 Phase 3
0.7143 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD4966 Approved
0.7134 Intermediate Similarity NPD4965 Approved
0.7134 Intermediate Similarity NPD4967 Phase 2
0.7132 Intermediate Similarity NPD74 Approved
0.7132 Intermediate Similarity NPD9266 Approved
0.7126 Intermediate Similarity NPD7229 Phase 3
0.7123 Intermediate Similarity NPD1283 Approved
0.7117 Intermediate Similarity NPD5761 Phase 2
0.7117 Intermediate Similarity NPD5760 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data